Chlordiazepoxide

氯氮䓬

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChlordiazepoxide
Drug Alias Name氯氮卓Chlordiazepoxidum氯西泊氯地庚波甲氨二氮卓 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersAnxietySleep Initiation and Maintenance Disorders +[5] 
Global Approved IndicationsAnxiety DisordersAnxietySleep Initiation and Maintenance Disorders +[5] 
Approved Indications in ChinaAnxietySleep Initiation and Maintenance DisordersEpilepsy +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1960/02/24
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMaruishi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMaruishi Pharmaceutical Co LtdHuazhong Pharmaceutical Co Ltd
Inactive CompaniesBausch Health Companies Inc
Active IndicationsAnxietySleep Initiation and Maintenance DisordersEpilepsy +[4] 
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN05BA02
Related LinksWikipediaDrugBankKEGG